Related Experiment Videos
Quantitative assessment of myocardial perfusion: is it of clinical relevance?
J C Stollfuss1, I Kosa, S Ziegler
1Nuklearmedizinische Klinik und Poliklinik der Technischen Iniversität München Klinikum rechts der Isar Munchen, Germany.
Insights
Positron emission tomography (PET) offers valuable insights into coronary artery disease (CAD). While quantitative PET data for myocardial blood flow is debated, it shows promise for early detection and treatment assessment in at-risk patients.
Area of Science:
- Nuclear Medicine
- Cardiovascular Imaging
- Diagnostic Cardiology
Background:
- Coronary artery disease (CAD) is a leading cause of death in Western countries.
- Traditional risk factors and symptoms have limited specificity for CAD diagnosis.
- Coronary angiography's binary classification of stenosis poorly correlates with actual blood flow.
Purpose of the Study:
- To evaluate the role of Positron Emission Tomography (PET) in diagnosing and managing coronary artery disease (CAD).
- To explore the diagnostic and prognostic value of quantitative myocardial blood flow (MBF) assessment using cardiac PET.
- To compare the utility of PET imaging with traditional methods for CAD evaluation.
Main Methods:
- Cardiac PET imaging utilizing N-13 ammonia and Rb-82 for myocardial perfusion assessment.
- Quantitative and qualitative (semiquantitative) analysis of myocardial blood flow.
- Review of existing literature on PET's clinical impact in CAD workup.
Main Results:
- Cardiac PET provides unique qualitative and quantitative data on myocardial perfusion, metabolism, and membrane function.
- N-13 ammonia and Rb-82 PET are validated techniques for MBF assessment.
- The clinical benefit of absolute MBF values for CAD diagnosis remains under discussion, with many centers favoring qualitative interpretation.
Conclusions:
- Quantitative MBF assessment by PET may offer advantages for evaluating treatment response and early detection of CAD in asymptomatic individuals.
- PET imaging holds significant potential for improving diagnostic accuracy and patient management in known or suspected CAD.
- Further research is needed to fully establish the role of quantitative MBF in routine clinical practice.
Abstract:
Positron emission tomography provides unique qualitative and quantitative information on myocardial perfusion, metabolism and membrane function which potentially has an important impact on diagnostic workup and treatment in patients with known or suspected coronary artery disease (CAD). CAD contributes up to one third of all deaths among persons between the ages of 35 to 60 in western countries. Risk factors and symptoms turned out to have low specificity to identify persons with the disease and thus, will not help to establish objective diagnostic workup. Assessing severity of CAD by coronary angiography and means of binary classification (disease yes/no) of morphological abnormalities, i.e. stenosis > 50%, has shown to poorly correlate with coronary blood flow and, thus, might not serve as an optimal reference standard for the disease. Cardiac PET using N-13 ammonia and Rb-82 represents a well validated and clinically usable technique for both quantitative and qualitative (semiquantitative) assessment of myocardial blood flow. However, the clinical benefit of absolute flow values for diagnosis and localisation of CAD remains controversial. Most centers rely on qualitative image interpretation due to the technical requirements for image processing needed for determination of absolute flow values. However, quantitative assessment of myocardial blood flow might offer advantages when measurement of coronary flow reserve in response to medical or interventional therapy is necessary and in addition may provide early detection of CAD in asymptomatic patients who have risk factors.